Spear Matthew A.

CIK 00017663021 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001766302

Recent Transactions

26 trades

Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-03-01+72,568→ 72,568 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-03-01+50,000→ 111,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-12-06$1.32/sh+10,000→ 61,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-12-06−10,000→ 70,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-09-09−10,000→ 80,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-09-09$1.32/sh+10,000→ 51,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-20−4,000→ 90,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-08-20$1.32/sh+4,000→ 45,485 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2021-08-20$8.79/sh−4,000→ 41,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-07-28−20,000→ 94,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-07-28$1.32/sh+20,000→ 41,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-17−5,000→ 114,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-06-17$1.32/sh+5,000→ 21,485 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2021-06-11$9.44/sh−4,000→ 16,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-11−4,000→ 119,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-06-11$1.32/sh+4,000→ 20,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-04-23$1.32/sh+5,000→ 16,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-23−5,000→ 123,861 total
Sale
Poseida Therapeutics, Inc.
Common Stock
2021-04-21$8.44/sh−4,000→ 11,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-04-21$1.32/sh+4,000→ 15,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-21−4,000→ 128,861 total
Award
Poseida Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-04+164,000→ 164,000 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-01-15$1.32/sh+7,564→ 11,485 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-15−7,564→ 132,861 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Common Stock
2021-01-08$1.32/sh+3,921→ 3,921 total
Exercise/Conversion
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-08−3,921→ 140,425 total

Companies

Poseida Therapeutics, Inc.
Chief Medical Officer

Recent Filings

Address

C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, STE 200

SAN DIEGO, CA, 92121

View on SEC.gov